UNSPSC 85501636: Replacement of left subclavian artery with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left subclavian artery with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03R40KZ

UNSPSC 85501636, Replacement of left subclavian artery with nonautologous tissue substitute, open approach, is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its medical procedure classification. The six recent opportunities tagged under this code span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, surgical and medical procedure carve-out benefits, independent medical evaluation services, and juvenile detention healthcare—none of which involve arterial replacement procedures or their associated implants and supplies. The mismatch suggests either systematic miscoding by issuing bodies or that this Commodity code is not in current use for state and local contracting.

The opportunities instead reflect state and local governments purchasing general occupational health services, health plan administration, and clinical staffing arrangements. Issuing bodies include the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation (on behalf of Washington State Ferries), Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System—a mix of municipal retirement systems, transportation authorities, county human services, and public health systems. Geographic activity appears concentrated in California, Arizona, Washington, and Florida. Without recent opportunities actually addressing the code's stated clinical procedure, there is insufficient signal to assess market demand, issuing-body concentration, or pursuit viability for vendors offering left subclavian artery replacement services or related devices to state and local buyers.